Z-0740-2020 Class II Terminated

Recalled by Ortho Clinical Diagnostics Inc — Raritan, NJ

FDA device recall Z-0740-2020 was initiated by Ortho Clinical Diagnostics Inc on Oct 14, 2019 and is designated Class II. Reason for recall: Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days. The recall status is terminated (terminated Nov 13, 2020). Affected quantity: 2,573.

Recall details

Product Type
Devices
Report Date
Jan 1, 2020
Initiation Date
Oct 14, 2019
Termination Date
Nov 13, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,573

Product description

Urine Electrolyte Diluent, Product Code: 1112352 - Product Usage: used to dilute urine specimens for analysis of sodium (Na+) and potassium (K+) on VITROS 250/350/5,1 FS/4600 Chemistry Systems and the VITROS 5600/XT 7600 Integrated Systems.

Reason for recall

Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days.

Distribution pattern

Worldwide distribution - US Nationwide distribution and countries BM, AU, BR, CA, CL, CN, CO, IN, JP, MX, SG, GB, FR, DE, IT, ES, PT, PL, RU, DK, NO, SE, BE, NL.

Code information

Lot with Expiry Date: V6391 2020-02-26 W6895 2020-09-20 X7127 2021-01-17 Y7593 2021-08-28

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0740-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0740-2020. Report a data issue: hello@regdatalab.com.